Is It Too Late To Consider Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT)?
LeMaitre Vascular, Inc. ( NASDAQ:LMAT ), is not the largest company out there, but it saw a double-digit share price...
Simply Wall St. · 5d ago
LeMaitre Vascular (NASDAQ:LMAT) Will Want To Turn Around Its Return Trends
There are a few key trends to look for if we want to identify the next multi-bagger. In a perfect world, we'd like to...
Simply Wall St. · 11/03 14:35
Weibo, XPeng, Li Auto And Other Big Losers From Friday
Benzinga · 10/31 09:44
Why Pinterest Shares Jumped Around 14%; Here Are 69 Biggest Movers From Friday
Benzinga · 10/31 08:13
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 10/28 17:59
BDTX and TCRX among mid-day movers
Seekingalpha · 10/28 16:53
Why Edwards Lifesciences Shares Are Trading Lower By Around 17%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
Benzinga · 10/28 16:12
LeMaitre stock slumps 16% amid Q3 miss, slashed outlook
Seekingalpha · 10/28 15:18
Benzinga's Top Ratings Upgrades, Downgrades For October 28, 2022
Benzinga · 10/28 14:12
Nuvalent, DexCom top healthcare gainers; DaVita, LeMaitre lead losers' pack
Seekingalpha · 10/28 14:02
Barrington Research Downgrades LeMaitre Vascular to Market Perform
Benzinga · 10/28 13:16
LeMaitre Vascular (LMAT) Misses Q3 Earnings and Revenue Estimates
LeMaitre (LMAT) delivered earnings and revenue surprises of -10.71% and 2.75%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 10/27 22:35
BRIEF-Lemaitre Q3 2022 Financial Results
Reuters · 10/27 21:37
LeMaitre Vascular Non-GAAP EPS of $1.05 beats by $0.77, revenue of $39.03M misses by $1.03M
Seekingalpha · 10/27 20:33
LeMaitre Vascular Q3 EPS $0.25 Misses $0.28 Estimate, Sales $39.00M Miss $40.06M Estimate
Benzinga · 10/27 20:19
-- Earnings Flash (LMAT) LEMAITRE VASCULAR Reports Q3 Revenue $39M
-- Earnings Flash (LMAT) LEMAITRE VASCULAR Reports Q3 Revenue $39M
MT Newswires · 10/27 16:31
Notable earnings after Thursday's close
Seekingalpha · 10/26 21:35
LeMaitre Will Announce Third Quarter 2022 Earnings Results October 27, 2022
BURLINGTON, Mass., Oct. 17, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its third quarter 2022 financial results on Thursday, October 27, 2022, after the market close. The company has scheduled a conf...
GlobeNewswire · 10/17 21:11
Those who invested in LeMaitre Vascular (NASDAQ:LMAT) three years ago are up 65%
One simple way to benefit from the stock market is to buy an index fund. But if you buy good businesses at attractive...
Simply Wall St. · 09/29 13:32
BRIEF-Lemaitre Vascular Says Board Appointed Martha Shadan As Director
BRIEF-Lemaitre Vascular Says Board Appointed Martha Shadan As Director
Reuters · 09/23 13:23
Webull provides a variety of real-time LMAT stock news. You can receive the latest news about Lemaitre Vasculr through multiple platforms. This information may help you make smarter investment decisions.
About LMAT
LeMaitre Vascular, Inc. is a provider of medical devices and human tissue cryopreservation services, which are used in the treatment of peripheral vascular disease, end-stage renal disease and to a lesser extent cardiovascular disease. The Company develops, manufactures and markets vascular devices to address the needs of vascular surgeons, and to a lesser degree, other specialties, such as cardiac surgeons, general surgeons and neurosurgeons. It sold its principal product in the United States, Europe, the United Kingdom, Canada and Asia Pacific. The Company sales its products and services primarily through a direct sales force. Its products and services offering includes Allografts, Angioscopes, Balloon Catheters for Embolectomy and Thrombectomy, Balloon Catheters for Occlusion and Perfusion, Bovine Grafts, Vascular and Cardiac Patches, Carotid Shunts, Closure Systems, Ovine Vascular Grafts, Polyester Vascular Grafts, ePTFE Vascular Grafts, Radiopaque Tape, and Valvulotomes.